IBM Attempts To Divest Watson Health This Time For Over $1B

January 5, 2022 12:54 PM | 29 seconds read |

International Business Machines Corp IBM revived its sale process for IBM Watson Health, Axios reports.
IBM looks to procure over $1 billion from the sale. IBM spent over $4 billion to build Watson Health via acquisitions.
Watson Health now includes health care data and analytics business Truven Health Analytics, population health company Phytel, and medical imaging business Merge Healthcare.
IBM first explored a sale of the division in early 2021.
Price Action: IBM shares traded higher by 2.71% at $141.75 on the last check Wednesday.

Posted In: News Asset Sales Tech Media Briefs

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.